Grace Therapeutics
GRCE
15 hedge funds and large institutions have $2.87M invested in Grace Therapeutics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
87% more capital invested
Capital invested by funds: $1.53M → $2.87M (+$1.33M)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$95.3K |
| 2 |
Renaissance Technologies
New York
|
+$11.1K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$3.86K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$140K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$130K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$9.56K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$335 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fiera Capital (Canada)
Montreal,
Quebec, Canada
| $1.55M | -$140K | -833 | -39% |
|
|
PA
2
Perceptive Advisors
New York
| $626K | – | – | – |
|
|
IIM
3
Intact Investment Management
Montreal,
Quebec, Canada
| $452K | – | – | – |
|
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $120K | -$130K | -773 | -45% |
|
|
5
1832 Asset Management
Toronto,
Ontario, Canada
| $69K | +$95.3K | +568 | New |
|
|
6
Renaissance Technologies
New York
| $17K | +$11.1K | +66 | +97% |
|
|
7
Citadel Advisors
Miami,
Florida
| $10K | -$9.56K | -57 | -43% |
|
|
8
UBS Group
Zurich,
Switzerland
| $4K | -$335 | -2 | -6% |
|
9
Geode Capital Management
Boston,
Massachusetts
| $4K | – | – | – |
|
|
AGM
10
Alpine Global Management
New York
| $3K | – | – | – |
|
|
VKH
11
Virtu KCG Holdings
New York
| $3K | +$3.86K | +23 | New |
|
|
EWM
12
Edge Wealth Management
New York
| $1K | – | – | – |
|
|
LTFS
13
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.34K | +8 | +400% |
|
GRCE Hedge Fund Activity: Q3 2015 in Review
15 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q3 2015, worth a combined $2.87M — up 87% from $1.53M a quarter earlier.
Fund positioning in GRCE was balanced in Q3 2015: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was 1832 Asset Management, opening a new position worth an estimated $95.3K. The largest seller was Fiera Capital (Canada), cutting an estimated $140K.
- 15 institutional investors held Grace Therapeutics (GRCE) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $2.87M of Grace Therapeutics stock for Q3 2015, up 87% quarter-over-quarter.
- 2 funds opened new Grace Therapeutics positions in Q3 2015 and 2 closed out, a net change of 0 holders.
- The largest Grace Therapeutics buyer in Q3 2015 was 1832 Asset Management, an estimated $95.3K added.
- The largest Grace Therapeutics seller in Q3 2015 was Fiera Capital (Canada), an estimated $140K sold.
Based on aggregated 13F filings for Q3 2015.